| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.681 | 5.775 | 3.918 | 2.849 | 4.714 | 2.526 | 2.203 | 4.417 | 2.260 | 3.580 |
| Total Income - EUR | 1.681 | 5.775 | 3.919 | 2.850 | 4.714 | 2.527 | 2.203 | 4.418 | 2.260 | 3.581 |
| Total Expenses - EUR | 371 | 2.917 | 2.738 | 1.926 | 3.253 | 2.057 | 1.315 | 1.793 | 1.492 | 1.541 |
| Gross Profit/Loss - EUR | 1.309 | 2.859 | 1.181 | 923 | 1.461 | 470 | 888 | 2.625 | 769 | 2.040 |
| Net Profit/Loss - EUR | 1.259 | 2.685 | 1.063 | 838 | 1.320 | 395 | 830 | 2.492 | 656 | 1.746 |
| Employees | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Callatis-Med.inf. Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 8.462 | 8.319 | 8.166 | 8.008 | 7.856 | 7.682 | 7.706 | 7.682 | 7.639 |
| Current Assets | 3.501 | 5.314 | 4.990 | 5.807 | 6.746 | 7.466 | 5.275 | 7.777 | 8.533 | 10.043 |
| Inventories | 357 | 354 | 348 | 341 | 0 | 0 | 0 | 0 | 572 | 0 |
| Receivables | 956 | 1.307 | 954 | 903 | 632 | 1.011 | 1.045 | 594 | 163 | 844 |
| Cash | 2.188 | 3.653 | 3.688 | 4.563 | 6.114 | 6.455 | 4.230 | 7.183 | 7.798 | 9.199 |
| Shareholders Funds | 206 | 2.889 | 1.264 | 1.034 | 1.513 | 1.879 | 2.668 | 5.168 | 5.809 | 6.953 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.295 | 10.887 | 12.045 | 12.938 | 13.241 | 13.442 | 10.289 | 10.315 | 10.407 | 10.512 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 217 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Callatis-Med.inf. Srl